Home / Buprenorphine / Czechia
CZ ATC N02AE01 · updated 2 Nov 2026
Buprenorphine shortage in Czechia
Is there a Buprenorphine shortage in Czechia?
Yes. As of 2 Nov 2026, 5 Buprenorphine products are reported short in Czechia, the first since 28 Apr 2026. The company estimate for the return is 30 Nov 2026 (latest 15 Jan 2027). Main reason: manufacturing problem.
Also short in Germany, Italy, Spain, Austria, Sweden, Australia. All countries.
Affected products in Czechia
| Country | Product | Company | Since | Expected back | Reason |
|---|---|---|---|---|---|
| CZ | BUPRENORFIN STADA 10MCG/H 10MCG/H TDR EMP 4 | STADA Arzneimittel AG, Bad Vilbel | 28 Apr 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | BUPRENORFIN STADA 30MCG/H 30MCG/H TDR EMP 4 | STADA Arzneimittel AG, Bad Vilbel | 29 Jul 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | BUPRENORFIN STADA 5MCG/H 5MCG/H TDR EMP 4 | STADA Arzneimittel AG, Bad Vilbel | 29 Jul 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
| CZ | BUPRENORFIN STADA 20MCG/H 20MCG/H TDR EMP 4 | STADA Arzneimittel AG, Bad Vilbel | 7 Sep 2026 | 15 Jan 2027 | Manufacturing problem Výrobní důvody |
| CZ | BUPRENORFIN STADA 40MCG/H 40MCG/H TDR EMP 4 | STADA Arzneimittel AG, Bad Vilbel | 14 Sep 2026 | 30 Nov 2026 | Manufacturing problem Výrobní důvody |
Source
SÚKL (State Institute for Drug Control), market reports. Official list. Products whose latest market report is a supply interruption; one row per SÚKL code.